Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Biogen Idec
(NQ:
BIIB
)
192.88
+3.41 (+1.80%)
Streaming Delayed Price
Updated: 9:58 AM EDT, May 22, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biogen Idec
< Previous
1
2
...
18
19
20
21
22
23
24
25
26
...
60
61
Next >
The Latest Analyst Ratings for Biogen
↗
December 07, 2023
Via
Benzinga
Doing Your Holiday Shopping? These Stocks Might Make Great Gifts
December 04, 2023
No matter which holiday you're planning gifts for, Christmas, Hanukkah, or some other occasion, there may be one great gift idea you haven't thought of yet.
Via
MarketBeat
Topics
Bonds
Comparative Study: Biogen And Industry Competitors In Biotechnology Industry
↗
November 28, 2023
Via
Benzinga
Here's How Much $1000 Invested In Biogen 20 Years Ago Would Be Worth Today
↗
November 16, 2023
Via
Benzinga
Industry Comparison: Evaluating Biogen Against Competitors In Biotechnology Industry
↗
November 14, 2023
Via
Benzinga
Expert Ratings for Biogen
↗
November 09, 2023
Via
Benzinga
Looking Into Biogen's Recent Short Interest
↗
November 06, 2023
Via
Benzinga
Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others
↗
November 21, 2023
Recent advancements in Alzheimer's disease treatments targeting the removal of toxic proteins (white matter) from the brain have sparked a renewed interest in developing vaccines to combat this
Via
Benzinga
Quest For Alzheimer's Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning
↗
November 17, 2023
Biotech companies are edging closer to finding the answers behind Alzheimer's disease.
Via
Investor's Business Daily
Stock Market Rally Pauses As Yields Rebound; Datadog, Affirm Among Earnings Winners: Weekly Review
↗
November 10, 2023
The major indexes ended long win streaks. Datadog led earnings winners.
Via
Investor's Business Daily
Here's How Much You Would Have Made Owning Biogen Stock In The Last 15 Years
↗
November 01, 2023
Via
Benzinga
Assessing Biogen's Performance Against Competitors In Biotechnology Industry
↗
October 30, 2023
Via
Benzinga
The Alzheimer's Drug Market Is Heating Up. Should You Buy the Leading Contenders' Stocks?
↗
November 10, 2023
The real competitive battle is about to begin, and it will last a long time.
Via
The Motley Fool
These Analysts Revise Their Forecasts On Biogen After Q3 Results
↗
November 09, 2023
Biogen Inc (NASDAQ: BIIB) reported better-than-expected third-quarter earnings.
Via
Benzinga
Thoughts For Thursday: Staying On Top - Barely
↗
November 09, 2023
The stock market continues to be full of worry, but is managing to stay on top this week, so far. It is worth noting that yesterday's close brought levels back to those of a month ago.
Via
Talk Markets
Biogen (BIIB) Q3 2023 Earnings Call Transcript
↗
November 08, 2023
BIIB earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Biogen Revises Annual Forecast As Reata M&A And Alzheimer's Drug Expenses Hit Bottomline, Stock Slides
↗
November 08, 2023
Biogen Inc (NASDAQ: BIIB) posted Q3 FY23 sales of $2.53 billion, beating the con
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
November 08, 2023
Via
Benzinga
Compared To Estimates, Biogen Inc. Q3 Earnings: A Look At Key Metrics
↗
November 08, 2023
Biogen Inc. reported $2.53 billion in revenue for the quarter ended September 2023.
Via
Talk Markets
US Stocks Set To Open Flat After Hot 7-Day Rally: Traders Sharpen Focus On Powell's Speech, Disney Earnings
↗
November 08, 2023
Stock futures indicate a subdued opening on Wednesday after several consecutive gains in major averages. Traders are eagerly awaiting Federal Reserve Chair Jerome Powell’s speech for insights into...
Via
Benzinga
Topics
Economy
Biogen Tops Earnings Forecasts, But Cuts Profit Outlook As Leqembi Expenses Mount
↗
November 08, 2023
The company shares in the profits and sales related to Alzheimer's treatment, Leqembi.
Via
Investor's Business Daily
3 Biotech Moonshots to Bet on the Future of Health
↗
November 06, 2023
Thanks to their potential blockbuster drugs, these three biotech stocks may yield huge returns for patent investors willing to take the risk.
Via
InvestorPlace
Topics
Intellectual Property
Biogen Appoints Monish Patolawala to its Board of Directors
November 06, 2023
Accomplished executive brings deep expertise leading global financial organizations and overseeing successful business transformation
From
Biogen Inc.
Via
GlobeNewswire
Biogen Pulls Prothena Into A Steep Dive On Mixed Results For Alzheimer's Treatment
↗
October 26, 2023
Both companies are working on under-the-skin injections for Alzheimer's treatment.
Via
Investor's Business Daily
Eisai Presents New LEQEMBI® (lecanemab-irmb) Investigational Subcutaneous Formulation Interim Study Results and Clinical Improvement Data in Earlier Stages of Early Alzheimer’s Disease From Additional Analyses of Clarity AD at The Clinical Trials On
October 25, 2023
From
Biogen Inc.
Via
GlobeNewswire
Biogen Says New Data Shows Promise For Potential New Generation Of Treatments In Early Alzheimer's Disease
↗
October 25, 2023
Biogen Inc. (NASDAQ: BIIB) reported new Phase 1b clinical data from the study of BIIB080, an investigational antisense oligonucleotide (ASO) therapy targeting tau,
Via
Benzinga
New Data from Biogen’s Investigational Antisense Oligonucleotide (ASO) Targeting Tau Shows Promise for Potential New Generation of Treatments in Early Alzheimer’s Disease
October 25, 2023
From
Biogen Inc.
Via
GlobeNewswire
An Oversold Small Cap Industrial That Insiders Are Buying Ahead Of Earnings This Week
↗
October 24, 2023
Another RSI Buy In a post last month, we wrote about the power of RSI (Relative Strength Index) as a technical indicator (Relative Strength Index) in relation to Stitch Fix, Inc. (NASDAQ: SFIX)
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
↗
October 23, 2023
Via
Benzinga
Biogen to Present New Data at the Clinical Trials on Alzheimer’s Disease (CTAD) 2023 Meeting
October 19, 2023
From
Biogen Inc.
Via
GlobeNewswire
< Previous
1
2
...
18
19
20
21
22
23
24
25
26
...
60
61
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
